Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration
Authors:
- Katerina RademacherKRKaterina Rademacher
- Zak DoricZDZak Doric
- Dominik HaddadDHDominik Haddad
- Aphroditi MamaligasAMAphroditi Mamaligas
- Szu-Chi LiaoSLSzu-Chi Liao
- Rose CreedRCRose Creed
- Kohei KanoKKKohei Kano
- Zac ChattertonZCZac Chatterton
- Yuhong FuYFYuhong Fu
- Joseph H GarciaJGJoseph H Garcia
- Victoria M VanceVVVictoria M Vance
- Yoshitaka J SeiYSYoshitaka J Sei
Open Access
- 26 August 2025
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Abstract
Parkinson’s disease (PD) is characterized by the death of substantia nigra pars compacta (SNc) dopamine (DA) neurons, but the pathophysiological mechanisms that precede and drive their death remain unknown. The activity of DA neurons is likely altered in PD, but we understand little about if or how chronic changes in activity may contribute to degeneration. To address this question, we developed a chemogenetic (DREADD) mouse model to chronically increase DA neuron activity and confirmed this increase using ex vivo electrophysiology. Chronic hyperactivation of DA neurons resulted in prolonged increases in locomotor activity during the light cycle and decreases during the dark cycle, consistent with chronic changes in DA release and circadian disturbances. We also observed early, preferential degeneration of SNc projections, recapitulating the PD hallmarks of selective vulnerability of SNc axons and the comparative resilience of ventral tegmental area axons. This was followed by the eventual loss of midbrain DA neurons. Continuous DREADD activation resulted in a sustained increase in baseline calcium levels, supporting a role for increased calcium in the neurodegeneration process. Finally, spatial transcriptomics from DREADD mice examining midbrain DA neurons and striatal targets, and cross-validation with human patient samples, provided insights into potential mechanisms of hyperactivity-induced toxicity and PD. Our results thus reveal the preferential vulnerability of SNc DA neurons to increased neural activity and support a potential role for increased neural activity in driving degeneration in PD.Keywords
All Related Versions
Funding Information
- Aligning Science Across Parkinson’s (ASAP-020529)
- National Institutes of Health (RO1NS091902)
- National Institutes of Health (RF1AG064170)
- National Institutes of Health (R01DA030529)
- National Institutes of Health (F31NS137765)
- California Department of Alcohol and Drug Programs
- Gladstone Institutes
- Burroughs Wellcome Fund
- Larry L. Hillblom Foundation
This publication has 107 references indexed in Scilit:
- In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's diseaseBrain and Behavior, 2023
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in miceMetabolic Brain Disease, 2019
- C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome‐wide meta‐analysisAnnals of Neurology, 2014
- A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouseBrain Structure and Function, 2011
- Characterization of a mouse strain expressing Cre recombinase from the 3′ untranslated region of the dopamine transporter locusGenesis, 2006
- Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease2006
- Gene expression profiling in the midbrain of striatal 6‐hydroxydopamine‐injected miceSynapse, 2003
- Intracellular and extracellular roles of S100 proteinsMicroscopy Research and Technique, 2003
- Neurochemical Compensation After Nigrostriatal Bundle Injury in an Animal Model of Preclinical ParkinsonismArchives of Neurology, 1984